| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.026 | 0.9 |